Abstract:N,N‐[(diethylamino)(thiocarbonyl)]‐substituted benzamidine ligands have been synthesized from the reaction of N,N‐[(diethylamino)(thiocarbonyl)]benzimidoyl chloride with functionalized amines such as 2‐aminophenol and 2‐picolylamine. The reaction of N,N‐[(diethylamino)(thiocarbonyl)]‐2‐hydroxyphenylbenzamidine (H2L1) with ruthenium(II) precursor [RuHCl(CO)(PPh3)3] afforded complex 1 of the type [Ru(L1)(CO)(PPh3)2] in which the ligand coordinated in tridentate ONS mode. The reaction of H2L1 with copper precursor [Cu(CH3COO)(PPh3)2] induced C═N bond cleavage of the ligand and afforded complex 3 of the type [Cu(1,1‐DT)(Cl)(PPh3)2] (1,1‐DT = 1,1‐diethylthiourea) in which the ligand coordinated in a monodentate fashion. The ligand N,N‐[(diethylamino)(thiocarbonyl)]‐2‐picolylbenzamidine (HL2) reacted with ruthenium(II) and copper(I) precursors to form complex 2 of the type [Ru(1,1‐DT)(Cl2)(CO)(PPh3)2] and complex 3, respectively, in which the ligand underwent C═N cleavage and coordinated in a monodentate fashion via C═S group. In complexes 1 and 2, the two triphenylphosphine co‐ligands coordinated in trans position whereas, in complex 3, the two triphenylphosphine co‐ligands coordinated in cis position. All the compounds were characterized using infrared, UV–visible, (1H, 13C, 31P) NMR, ESI‐MS and elemental analyses. The molecular structures of ligand H2L1 and complexes 1–3 were determined using X‐ray crystallography, which confirmed the coordination mode of the ligands with metals. The crystal structure of complexes 1 and 2 revealed a distorted octahedral geometry around the ruthenium ion and the structure of complex 3 indicated a tetrahedral geometry around the copper ion. With the X‐ray structures, density functional theory computations were carried out to determine the electronic structure of the compounds. The interactions of complexes 1–3 with calf thymus DNA and bovine serum albumin protein were investigated using UV–visible and fluorescence spectroscopic and viscometric methods. Catecholase‐ and phosphatase‐like activities promoted by complexes 1–3 under physiological conditions have been studied. In vitro anticancer activities have been demonstrated by MTT assay, acridine orange/ethidium bromide and diamidino‐2‐phenylindole staining against various cancerous cell lines.

Synthesis and Structural Characterization of a Novel Ruthenium(II)- Histidine Complex

A Ruthenium(ii) Complex Having a Ligand Undergoing Partial C = N Cleavage and Unusual Double-Bond Shift and Nonchirality

Solvent-Assisted Formation of Ruthenium(Ii)/Copper(I) Complexes Containing Thiourea Derivatives: Synthesis, Crystal Structure, Density Functional Theory, Enzyme Mimetics and in Vitro Biological Perspectives

Chelate ring-opening ruthenium complexes: X-ray crystal structure and solution studies of cis, trans-bis(2-dimethyl-aminoethyl)-diphenyl-phosphino(dichloro)ruthenium(II)

Synthesis and Computational Investigations of Ruthenium(II) Complexes Containing Hydrazine Schiff Base Ligands

Synthesis, Structures, and Properties of Ruthenium(ii) Complexes of N-(1,10-phenanthrolin-2-yl)imidazolylidenes

Synthesis and Structural Characterization of Ruthenium(ii) Carbonyl Complexes with a Bistriazole N-heterocyclic Carbene Ligand

Antibacterial and ct-DNA binding studies of new synthesized ruthenium (III) hydroxamate complexes: Design, synthesis, DFT calculations and in-vitro study

Synthesis, Characterization, and DNA‐Binding Properties of the Chiral Ruthenium(II) Complexes Δ‐ and Λ‐[Ru(bpy)2(dmppd)]2+ (dmppd = 10,12‐dimethylpteridino[6,7‐f] [1,10]phenanthroline‐11,13(10h,12h)‐dione; Bpy = 2,2′‐Bipyridine)

SYNTHESIS, STRUCTURE, AND MECHANISM OF HALF-SANDWICH RUTHENIUM COMPLEX CONTAINING ORTHO-CARBORANE-1,2-DITHIOLATE LIGAND AND 1-PHENYL-2-PROPYN-1-OL

Preparation, Characterization, and Catalytic Properties of Ruthenium(II) Nitrosyl Complexes with Α-Diimine Ligands

Synthesis, spectroscopic characterization and crystal structure of cis-(bipyridine)2ruthenium(II) complexes containing nicotinoyl and isonicotinoyl hydrazone as ligands

THE SYNTHESIS AND STRUCTURE STUDIES ON CYCLOPENTADIENYLRUTHENIUM DERIVATIVES - THE CRYSTAL-STRUCTURE OF [(C5H5)RU(PPH3)(MU-H)]2

Synthesis, Cytotoxicity, and Biomacromolecule Binding: Three Isomers of Nitrosylruthenium Complexes with Bidentate Bioactive Molecules As Co-Ligands

Synthesis and characterization of new ruthenium(II) complexes containing coupled di(2-pyridyl) and 1,3-dithiole units

Synthesis and Characterization of Η5-1,2,4-diazaphospholide Complexes of Ruthenium

Homoleptic ruthenium(II) complexes bearing imidazol(in)ium-2-dithiocarboxylate ligands: synthesis, characterization, and redox properties

Fortuitous synthesis of unsaturated half-sandwich Ruthenium(II) complexes via solvent-involved rearrangement and their biological evaluation

Thermally Stable Heteroleptic trans‐Bis(chelate) Ruthenium(II) Complex Bearing 2,2'‐Bipyridine and Acetylacetonato: Synthesis, Isomerization, and Crystal Structure

Synthesis and characterization of novel Ru(III) complexes of 2‐aminopyrazine: Interaction with biomolecules, antineoplastic activity, and computational investigation

Hydrogen-bonding ruthenium complex [C22H24N3]2[RuCl6]·4CH2Cl2: Structure and catalytic properties